| LGND Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LGND shares outstanding history going back to 7/26/2010:
Also see: LGND Market Cap History LGND YTD Return |
LGND Shares Outstanding History — Ligand Pharmaceuticals Share Count Over Time
As of 5/5/2026 Ligand Pharmaceuticals has 20.04 million LGND shares outstanding. Investors often track the LGND shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows LGND share count trends over time, with 59 historical shares outstanding datapoints presented, dating back to 7/26/2010.
| LGND Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LGND Historical Shares Outstanding: -13.54% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LGND Stock Price Chart |
| About Ligand Pharmaceuticals Inc |
| Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. Co. does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several U.S. Food and Drug Administration (FDA)-approved products, including Gilead's Veklury, Amgen's Kyprolis, Baxter International's Nexterone, Melinta Therapeutics' Baxdela and Sage Therapeutics' Zulresso. We show 59 historical shares outstanding datapoints in our coverage of LGND's shares outstanding history. Understanding the changing numbers of LGND shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LGND versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LGND by allowing them to research LGND shares outstanding history as well as any other stock in our coverage universe. |
| LGND Current Stock Quote |
Quotes delayed 20 minutes  Free LGND Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| LGND Share Performance |
| Shares Outstanding Peers |
| Ligand Pharmaceuticals (LGND) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LGVN Shares Outstanding History LH Shares Outstanding History LHCG Shares Outstanding History LHDX Shares Outstanding History LIFE Shares Outstanding History LIPO Shares Outstanding History LITS Shares Outstanding History LIXT Shares Outstanding History LJPC Shares Outstanding History LLY Shares Outstanding History More Healthcare companies » |
LGND Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
